About Alliqua
Alliqua is a publicly listed company based in Yardley (United States) founded in 1997. Wound care solutions through transdermal drug delivery. Alliqua has completed 2 acquisitions, including Celleration and Choice Therapeutics. Alliqua offers products and services including Custom Hydrogels and Hydrogel Manufacturing Platform. Its focus areas include Life Sciences, Drug Delivery and Patches. Its legal entity is Alliqua BioMedical, Inc. Its competitors include scPharmaceuticals, Valeritas and Incline Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Alliqua was founded in 1997 as a biomedical company based in Yardley, United States. Operations focus on the development, manufacturing, and marketing of proprietary wound care products, including SilverSeal Hydrogel for antimicrobial applications and Hydress for moist wound management. A core transdermal delivery platform is utilized to enable drug and ingredient absorption through the skin, supporting advancements in the healthcare sector.
- Headquarters Yardley, United States
- Stage Public
- SectorsHealthcare
- Website alliqua.com
- Social LinkedIn X Facebook
- Legal Name Alliqua Biomedical, Inc.
- Annual Revenue$2.22 M (USD)10as on Dec 31, 2018
- Net Profit-$8.42 M (USD)67as on Dec 31, 2018
- EBITDA-$5.3 M (USD)-11as on Dec 31, 2018
- Latest Funding Round$2.77M (USD), Post-IPO
Mar 2017
- Investors
- Investments & AcquisitionsCelleration
& 1 more
Products & Services of Alliqua
Alliqua offers a comprehensive portfolio of products and services, including Custom Hydrogels and Hydrogel Manufacturing Platform.
Hydrogels for wound healing and skin care delivery
Platform for electron-beam cross-linked gels in healthcare
Funding Insights of Alliqua
- Total Rounds 15
- Last Round Post-IPO — $2.77M
- First Round $1.43M
(May 2010)
- Investors Count 1
Latest 10 of 15 funding rounds of Alliqua with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $2.77M | Post-IPO | – | – | – |
| Jun 2016 | Debt – Conventional | – | – | – | |
| May 2015 | $15.5M | Debt – Conventional | – | – | |
| Apr 2014 | $14.98M | Post-IPO | – | – | – |
| Nov 2013 | $7M | Post-IPO | – | – | – |
| Nov 2013 | $6M | Post-IPO | – | – | – |
| Nov 2013 | $651,578 | Post-IPO | – | – | – |
| Nov 2013 | $1M | Post-IPO | – | – | – |
| Jul 2013 | $3M | Post-IPO | – | – | – |
| Jun 2013 | $1.1M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Alliqua
Alliqua has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States |
Investor details for Alliqua
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alliqua
4 people are tracked at Alliqua (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Pam Unger | VP of Health Policy and Market Access | Leadership |
Gregory Robb | VP Operations | Leadership |
Robyn Kingsbury HOME | Account Executive | Team |
Christopher Indelicato | Territory Manager | Team |
Complete people profiles for Alliqua
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alliqua
Alliqua has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Celleration and Choice Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Ultrasound technology for wound healing is developed and marketed. | celleration.com | Eden Prairie, United States | 1999 | Feb 2015 | •••• | |
Wound care products for burns and surgical infections are manufactured. | choicetherapeutics.com | Wrentham, United States | 2006 | May 2014 | $4M |
Complete acquisition details for Alliqua
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Alliqua
6 dated milestones of Alliqua across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Alliqua is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.4M.
- Acquisition Acquires Choice Therapeutics.
- Acquisition Acquires Celleration.
- Funding Latest funding round, Post-IPO, of $2.8M.
Competitors of Alliqua
Alliqua has 3 listed competitors in our database, 3 of them funded. They include scPharmaceuticals, Valeritas and Incline Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| scpharmaceuticals.com | 2013 | Lexington, United States | $78.75M | 96 | Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure | |
| valeritas.com | 2003 | Bridgewater, United States | $181.36M | 141 | Wearable insulin patch pumps are developed for transdermal delivery. | |
| inclinethera.com | 2009 | Redwood, United States | $43.94M | Hospital-focused specialty pharmaceuticals are developed for acute pain management. |
Detailed competitors of Alliqua
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Alliqua
The website of Alliqua (alliqua.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 54.5% vs previous month
Websites whose visitors overlap most with Alliqua. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
woundcareshop.com | woundcareshop.com | 100% | #6,588,498 | – | |
| woundsource.com | 100% | #389,677 | View details | ||
aawconline.org | aawconline.org | 100% | #9,185,358 | – | |
wcei.net | wcei.net | 100% | #438,931 | – | |
progressivedoctors.com | progressivedoctors.com | 81% | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Alliqua (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alliqua
Complete news archive for Alliqua
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alliqua
Alliqua was founded in 1997 and raised its 1st funding round 13 years after it was founded.
Alliqua is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
Annual revenue of Alliqua is $2.22M as on Dec 31, 2018.
Alliqua was founded in 1997 as a biomedical company based in Yardley, United States. Operations focus on the development, manufacturing, and marketing of proprietary wound care products, including SilverSeal Hydrogel for antimicrobial applications and Hydress for moist wound management. A core transdermal delivery platform is utilized to enable drug and ingredient absorption through the skin, supporting advancements in the healthcare sector.
Alliqua's top competitors include scPharmaceuticals, Valeritas and Incline Therapeutics.
Alliqua offers Custom Hydrogels and Hydrogel Manufacturing Platform.
Alliqua has made 2 acquisitions, including Celleration, and Choice Therapeutics.
Alliqua has 1 investor. Key investors include Perceptive Advisors.
Alliqua operates through Alliqua Biomedical, Inc..